July 21, 2006

UNITED STATES OF AMERICA EX REL. DONALD R. GALMINES v. NOVARTIS PHARMACEUTICALS CORPORATION

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 05, 2016

    Novartis Pays $35M To End Elidel Off-Label Marketing Suit

    Novartis AG will pay more than $35 million to end a suit in Pennsylvania federal court accusing it of violating federal and state false claims acts by marketing the eczema cream Elidel for use on infants, even though it was only approved for older patients, the whistleblower said Wednesday.

7 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login